We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
"Inadequate Response": Suboptimal, Treatment Resistance, and Pseudo Resistance in Individuals with MDD
Denise Vanacore, PhD, FNP-BC, PMHNP-BC
MDD Treatment: Decisions With Switching, Augmenting, or Staying the Course
Symptom-Based Treatment Using Measurement-Based Care in Patients With MDD
Catherine Sheahan, APRN, PMHNP-BC, FNP-BC
Novel Therapeutics Treating the Adverse Events From SSRI and SNRI Monotherapy
New and Emerging Treatment Strategies for MDD: Addressing Emotional Blunting and Other Adverse Events
A New Era of Schizophrenia Disease Management: TAAR1 and M1/M4 Muscarinic Agonist
Leslie Citrome, MD, MPH
Christoph U. Correll, MD
Jonathan M. Meyer
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education